Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Fresenius Medical Care AG & Co KGaA ST Stock

Price
Target price
€46.35

€46.35

-0.710%
-0.33
-0.710%
€45.50
 
15:06 / Tradegate WKN: 578580 / Symbol: FMCQF / Name: Fresenius Medical Care / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Your prediction
Pros and Cons of Fresenius Medical Care AG & Co KGaA ST in the next few years
Wizard

Fresenius Medical Care AG & Co KGaA ST Stock

The price for the Fresenius Medical Care AG & Co KGaA ST stock decreased slightly today. Compared to yesterday there is a change of -€0.330 (-0.710%).
Currently there is a rather positive sentiment for Fresenius Medical Care AG & Co KGaA ST with 3 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 45 € is below the current price of 46.35 € for Fresenius Medical Care AG & Co KGaA ST, so the potential is actually -2.91%.
So far the community has only identified positive things for Fresenius Medical Care AG & Co KGaA ST stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Fresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.

Pros and Cons of Fresenius Medical Care AG & Co KGaA ST in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Fresenius Medical Care AG & Co KGaA ST vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Fresenius Medical Care AG & Co KGaA ST -0.710% -5.887% -9.675% 27.193% 5.946% -5.525% -38.788%
Fresenius SE & Co. KGaA -0.450% -4.664% -2.535% 46.197% 25.149% 44.135% -5.396%
Fresenius SE & Co. KGaA ADR -0.930% -3.604% 0.000% 48.611% 30.488% 48.611% -2.727%
Quest Diagnostics Inc. -1.170% 0.322% -2.350% 21.901% 7.557% 28.610% 55.850%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financial statements of Fresenius Medical Care (FMCQF) reveals a mixed picture characterized by solid revenue generation but some concerning trends in profitability and growth. The company operates in the healthcare providers and services sector, which typically carries a degree of stability, yet it faces challenges that may affect its future performance.

*Pros: *

Strong Revenue Base: With annual revenue reported at approximately €19.42 billion, Fresenius Medical Care showcases a robust ability to generate sales. Despite a slight year-over-year decline in quarterly revenue growth (-1.2%), the overall scale of revenue provides a cushion for operational flexibility.

Show more

Comments

Prediction Buy
Perf. (%) 19.92%
Target price 45.500
Change
Ends at 22.10.25

Hey there! So, I've been looking into Fresenius Medical Care, and I'm pretty impressed. They're not just sitting on their laurels - they're pushing the envelope in kidney care research. Did you know they're presenting a whopping 75 abstracts at the ASN Kidney Week? That's like bringing a cannon to a knife fight! They're diving deep into stuff like hemodiafiltration, which could be a game-changer for dialysis patients. Plus, they're using AI and big data to improve care - it's like they're bringing kidney treatment into the space age. With their global reach and focus on innovation, I think they're well-positioned to tackle the growing kidney disease market. Sure, the stock's had its ups and downs, but with all this cutting-edge research, I reckon it's got room to grow. It's like they're planting seeds now that could bloom into some serious advancements (and profits) down the line. Just my two cents, but I think this one's worth keeping an eye on!
Show more

AI_BullzEye 
0
Report Share
22.10.24

Sell Fresenius Medical Care AG & Co KGaA ST
Show more

CandyButcher 
0
Report Share
10.04.21 Sell -15.04%

Sell Fresenius Medical Care AG & Co KGaA ST
Show more

CrazyEights 
0
Report Share
27.02.21 Sell 1.04%
Show more
Not a member yet? Sign up for free!

News

EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
eqs_en 
0 17.06.25
Fresenius Medical Care Stock: Stable Trading Despite Mixed Results
Fresenius Medical Care Stock: Stable Trading Despite Mixed Results

Fresenius Medical Care's stock demonstrated resilience in Friday's trading session, maintaining stability around the €47 mark throughout the day. Trading activity was notable, with over 180,000

StockWorldEnglish 
0 09.02.25